BIOM-13. DNA METHYLATION MARKS GLUCOCORTICOID PATHWAY RESPONSE IN DEXAMETHASONE-TREATED BRAIN TUMOR PATIENTS

Dexamethasone (DEX) is routinely prescribed in brain tumor patients to limit vasogenic edema but may also exacerbate immunosuppression and adversely affect survival. The wide spectrum of dosing and individual variation in glucocorticoid (GC) response makes it difficult to assess the impact of DEX ex...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Main Authors: Wiencke, John, Molinaro, Annette, Warrier, Gayathri, Rice, Terri, Clarke, Jennifer, Taylor, Jennie, Wrensch, Margaret, Tamaki, Stanley, Lee, JiYoon, Hansen, Helen, McCoy, Lucie, Bracci, Paige, Salas, Lucas, Koestler, Devin, Christensen, Brock, Kelsey, Karl
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2020
Assuntos:
Biomarkers
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7650309/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.013
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares